Your browser doesn't support javascript.
loading
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome.
Cheng, Robert Y S; Ridnour, Lisa A; Wink, Adelaide L; Gonzalez, Ana L; Femino, Elise L; Rittscher, Helene; Somasundaram, Veena; Heinz, William F; Coutinho, Leandro; Rangel, M Cristina; Edmondson, Elijah F; Butcher, Donna; Kinders, Robert J; Li, Xiaoxian; Wong, Stephen T C; McVicar, Daniel W; Anderson, Stephen K; Pore, Milind; Hewitt, Stephen M; Billiar, Timothy R; Glynn, Sharon A; Chang, Jenny C; Lockett, Stephen J; Ambs, Stefan; Wink, David A.
Afiliação
  • Cheng RYS; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Ridnour LA; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Wink AL; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD, USA.
  • Gonzalez AL; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Femino EL; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Rittscher H; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Somasundaram V; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Heinz WF; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD, USA.
  • Coutinho L; Center for Translational Research in Oncology, ICESP/HC, Faculdade de Medicina da Universidade de São Paulo; and Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, SP, Brazil.
  • Rangel MC; Center for Translational Research in Oncology, ICESP/HC, Faculdade de Medicina da Universidade de São Paulo; and Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, SP, Brazil.
  • Edmondson EF; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for NCI, Frederick, MD, USA.
  • Butcher D; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for NCI, Frederick, MD, USA.
  • Kinders RJ; Office of the Director, Division of Cancer Treatment and Diagnosis, NCI, Frederick, MD, USA.
  • Li X; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Wong STC; Systems Medicine and Bioengineering Department, Houston Methodist Neal Cancer Center, Houston Methodist Hospital and Weill Cornell Medicine, Houston, TX, USA.
  • McVicar DW; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Anderson SK; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Pore M; Imaging Mass Cytometry Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Hewitt SM; Laboratory of Pathology CCR, NCI, NIH, Bethesda, MD, USA.
  • Billiar TR; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.
  • Glynn SA; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland.
  • Chang JC; Mary and Ron Neal Cancer Center, Houston Methodist Hospital and Weill Cornell Medicine, Houston, TX, USA.
  • Lockett SJ; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD, USA.
  • Ambs S; Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, MD, USA.
  • Wink DA; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA. wink@mail.nih.gov.
Cell Death Dis ; 14(5): 319, 2023 05 11.
Article em En | MEDLINE | ID: mdl-37169743
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Interferon gama / Microambiente Tumoral / Neoplasias de Mama Triplo Negativas Limite: Female / Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Interferon gama / Microambiente Tumoral / Neoplasias de Mama Triplo Negativas Limite: Female / Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos